SCHEMBL29566832

SCHEMBL29566832

CCc1c(Oc2cccc(N3CCN(C)CC3)c2Cl)nc(NS(=O)(=O)c2cnn(Cc3ccccc3)c2)nc1-c1ccccc1OCC(C)C

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 6/20 0.32
▸ HTR1A P08908 5/20 0.31
▸ DRD2 P14416 2/20 0.31
▸ HTR2A P28223 2/20 0.31
▸ DRD4 P21917 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ DRD3 P35462 1/20 0.31
▸ PAK1 Q13153 2/20 0.31
▸ HTR7 P34969 4/20 0.31
▸ CFTR P13569 1/20 0.31
▸ DCLK1 O15075 1/20 0.31
▸ LRRK2 Q5S007 1/20 0.31
▸ BRD4 O60885 2/20 0.30
▸ BRPF1 P55201 1/20 0.30
▸ BRD9 Q9H8M2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ HRH4 Q9H3N8 1/20 0.30
▸ TNIK Q9UKE5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309428 1.00 EGFR (0.32) EGFRHTR1ADRD2HTR2ADRD4
SCHEMBL24309950 0.94 PAK1 (0.36) EGFRHTR1ADRD2HTR2ADRD4
SCHEMBL29567289 0.94 PAK1 (0.36) EGFRHTR1ADRD2HTR2ADRD4
SCHEMBL29567063 0.92 EGFR (0.36) EGFRHTR1ADRD2HTR2ADRD4
SCHEMBL24309999 0.92 EGFR (0.36) EGFRHTR1ADRD2HTR2ADRD4
SCHEMBL29566861 0.92 HTR1A (0.36) EGFRHTR1ADRD2HTR2ADRD4
SCHEMBL26811393 0.92 HTR1A (0.36) EGFRHTR1ADRD2HTR2ADRD4
SCHEMBL24309904 0.90 HTR1A (0.33) EGFRHTR1ADRD2HTR2ADRD4
SCHEMBL24309884 0.89 DRD2 (0.36) HTR1ADRD2HTR2ADRD4HTR2C
SCHEMBL29566593 0.89 DRD2 (0.36) HTR1ADRD2HTR2ADRD4HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback